Patient Name: K ESWAR CHANDRA Ref. Doctor: Dr.K R .

Nikhila
Patient Id: 0001729851 Lab Id: 12232743211
OP Id: HY-BHS-1223-00023 Sample Collection Date & Time: 09/10/2024 11:23 AM
Age/Gender: 19 Years/Male Reporting Date & time: 09/10/2024 08:27 PM

HAEMATOLOGY
COMPLETE BLOOD COUNT
Investigation Result Normal Reference Range

Specimen:Blood (K2EDTA)
Total Leukocyte Count 7.19 X 10³/uL 4.0-10.0 X 10³/uL
(Method: Flowcytometry)

Total Red Blood Cell Count 5.81 X10¹²/L 4.5 - 5.5 X 10¹²/L
(Method: Hydrodynamic Focussing Method)

Hb 15.9 g/dL 13.0 - 17.0 g/dL

(Method: SLS - HB)

HCT 48.4 % 40 - 50 %
(Method: Calculated)

Mean Corpuscular Volume (MCV) 83.3 fl 83 - 101 fl

(Method: RBC Histogram)

Mean Corpuscular Hemoglobin (MCH) 27.4 pg 27 - 32 pg

(Method: Calculated)

MCHC 32.9 g/dl 31.5 - 34.5 g/dl

(Method: Calculated)

Platelet Count 312 X 10³/uL 150 - 410 X 10³/uL

(Method: Hydrodynamic Focussing Method)

DIFFERENTIAL LEUKOCYTE COUNT

Neutrophils 45.5 % 2.0-7.5 X 10³/uL (40 - 80%)
Lymphocytes 44.1 % 1.0-4.0 X 10³/uL (20 - 40%)
Monocytes 7.4 % 0.2-1.0 X 10³/uL(2 - 10%)
Eosinophils 2.6 % 0.02-0.5 X 10³/uL (1-6%)
Basophils 0.4 % 0.02 - 0.1 X 10³/uL (1-2%)
Method Flowcytometry
Notes --
*** END OF REPORT ***

https://tdiagnostics.telangana.gov.in/ViewFiles.aspx?ReportId=ZObjwyMeyYW0qG55yn7Crg== 11/13/24, 3 58 PM
Page 1 of 13
:
 Test Performed By : Clpath Consultant Pathologist

https://tdiagnostics.telangana.gov.in/ViewFiles.aspx?ReportId=ZObjwyMeyYW0qG55yn7Crg== 11/13/24, 3 58 PM
Page 2 of 13
:
 Lab Address: Telangana Diagnostics , Central Lab , IPM Campus, Narayanaguda, Hyd - 500029.

Patient Name: K ESWAR CHANDRA Ref. Doctor: Dr.K R .Nikhila

Patient Id: 0001729851 Lab Id: 12232743211
OP Id: HY-BHS-1223-00023 Sample Collection Date & Time: 09/10/2024 11:23 AM
Age/Gender: 19 Years/Male Reporting Date & time: 09/10/2024 05:10 PM

CLINICAL BIOCHEMISTRY
Investigation Result Biological Reference Interval

Specimen:Whole Blood
HbA1c 5.9 % 4-6%
(Method: Immunoturbidimetry)

Interpretation : HbA1c is a form of hemoglobin that is measured primarily to identify the three-month average plasma
glucose concentration
*** END OF REPORT ***

Please correlate clinically

Test Performed By : cljyothi Consultant Biochemist

https://tdiagnostics.telangana.gov.in/ViewFiles.aspx?ReportId=ZObjwyMeyYW0qG55yn7Crg== 11/13/24, 3 58 PM
Page 3 of 13
:
 Patient Name: K ESWAR CHANDRA Ref. Doctor: Dr.K R .Nikhila
Patient Id: 0001729851 Lab Id: 12232743211
OP Id: HY-BHS-1223-00023 Sample Collection Date & Time: 09/10/2024 11:23 AM
Age/Gender: 19 Years/Male Reporting Date & time: 09/10/2024 05:56 PM

CLINICAL BIOCHEMISTRY
LIPID PROFILE
Investigation Result Biological Reference Interval

Specimen:Serum
S.Total Cholesterol 161 mg/dL Desirable Level : <200 mg/dL
(Method: CHOD-POD)
Borderline : 200 - 239 mg/dL
Undesirable : > 240 mg/dL
S.Triglycerides 135 mg/dL Desirable Level : <150 mg/dL
(Method: GPO-POD)
Borderline : 150 - 199 mg/dL
High : 200 - 499 mg/dL
Very High : >500 mg/dL
S.HDL 43 mg/dL Desirable Level : >60 mg/dL
(Method: Enzyme Selective Inhibition) Borderline : 40 - 59 mg/dL
Undesirable : <40 mg/dL
VLDL 27 mg/dL <30 mg/dL
(Method: Calculated)

S.LDL 91 mg/dL Optimal : <100 mg/dL

(Method: Calculated) Near Optimal : 100 - 129
mg/dL
Borderline High : 130 - 159
mg/dL
High : 160 - 189 mg/dL
Very High : >190 mg/dL
T.Chol/HDL 3.7 Low Risk: 3.3-4.4
(Method: Calculated) Average Risk: 4.5-7.1
Moderate Risk: 7.2-11.0
LDL/HDL 2.1 Desirable Level: 0.5-3.0
(Method: Calculated) Borderline Risk: 3.0-6.0
High Risk: >6.0

https://tdiagnostics.telangana.gov.in/ViewFiles.aspx?ReportId=ZObjwyMeyYW0qG55yn7Crg== 11/13/24, 3 58 PM
Page 4 of 13
:
 Interpretation : The results of this test can identify certain genetic diseases and can determine approximate risks for
cardiovascular disease, certain forms of pancreatitis, and other diseases
*** END OF REPORT ***

Please correlate clinically

Test Performed By : cldakshyyani Consultant Biochemist

https://tdiagnostics.telangana.gov.in/ViewFiles.aspx?ReportId=ZObjwyMeyYW0qG55yn7Crg== 11/13/24, 3 58 PM
Page 5 of 13
:
 Patient Name: K ESWAR CHANDRA Ref. Doctor: Dr.K R .Nikhila
Patient Id: 0001729851 Lab Id: 12232743211
OP Id: HY-BHS-1223-00023 Sample Collection Date & Time: 09/10/2024 11:23 AM
Age/Gender: 19 Years/Male Reporting Date & time: 09/10/2024 08:23 PM

CLINICAL BIOCHEMISTRY
LIVER FUNCTION TEST
Investigation Result Biological Reference Interval

Specimen:Serum
S. Bilirubin T 1.20 mg/dL 0.3 - 1.2 mg/dL
(Method: DPD)

S. Bilirubin D 0.21 mg/dL <0.2 mg/dL

(Method: DPD)

S.Total Protein 6.72 gm/dL 5.7 - 8.0 gm/dL

(Method: Biuret)

S.Albumin 3.73 gm/dL 3.5 - 5.2 gm/dL

(Method: BCG)

Globulin 2.99 gm/dL 2.6-3.9 gm/dL

(Method: Calculated)

A/G Ratio 1.25 1.0 - 1.7

(Method: Calculated)

SGOT/AST 20 U/L < 50 U/L

(Method: UV without P5P)

SGPT /ALT 13 U/L < 50 U/L

(Method: UV without P5P)

S.Alkaline Phosphatase 101 U/L 52 - 171 U/L

(Method: IFCC)

Interpretation : Liver function tests (LFTs or LFs) are groups of blood tests that give information about the state of a
patient's liver. Liver transaminases (AST or SGOT and ALT or SGPT) are useful biomarkers of liver
injury in a patient with some degree of intact liver function. Some tests are associated with functionality
(e.g., albumin), some with cellular integrity (e.g., transaminase), and some with conditions linked to the
biliary tract (gamma-glutamyl transferase and alkaline phosphatase). GGT plays a role in the detection of
alcoholism, alcoholic liver damage and in monitoring alcohol abstinence.
*** END OF REPORT ***

Please correlate clinically

https://tdiagnostics.telangana.gov.in/ViewFiles.aspx?ReportId=ZObjwyMeyYW0qG55yn7Crg== 11/13/24, 3 58 PM
Page 6 of 13
:
 Test Performed By : cljyothi Consultant Biochemist

https://tdiagnostics.telangana.gov.in/ViewFiles.aspx?ReportId=ZObjwyMeyYW0qG55yn7Crg== 11/13/24, 3 58 PM
Page 7 of 13
:
 Patient Name: K ESWAR CHANDRA Ref. Doctor: Dr.K R .Nikhila
Patient Id: 0001729851 Lab Id: 12232743211
OP Id: HY-BHS-1223-00023 Sample Collection Date & Time: 09/10/2024 11:24 AM
Age/Gender: 19 Years/Male Reporting Date & time: 10/10/2024 04:15 AM

CLINICAL BIOCHEMISTRY
THYROID PROFILE
Investigation Result Biological Reference Interval

Specimen:Serum
T3 - Total 1.01 ng/mL 0.86-1.92 ng/mL
(Method: CLIA)

T4 -Total 7.1 µg/dL 5.5-11.1 µg/dL

(Method: CLIA)

Thyroid stimulating hormone (TSH) 3.207 µIU/mL 0.7-6.4 µIU/mL

(Method: CLIA)

Interpretation

*** END OF REPORT ***

Please correlate clinically

Test Performed By : cljyothi Consultant Biochemist

https://tdiagnostics.telangana.gov.in/ViewFiles.aspx?ReportId=ZObjwyMeyYW0qG55yn7Crg== 11/13/24, 3 58 PM
Page 8 of 13
:
 Patient Name: K ESWAR CHANDRA Ref. Doctor: Dr.K R .Nikhila
Patient Id: 0001729851 Lab Id: 12232743211
OP Id: HY-BHS-1223-00023 Sample Collection Date & Time: 09/10/2024 11:23 AM
Age/Gender: 19 Years/Male Reporting Date & time: 09/10/2024 08:12 PM

CLINICAL BIOCHEMISTRY
RENAL FUNCTION TEST
Investigation Result Biological Reference Interval

Specimen:Serum
Blood Urea 29 mg/dL 10.8 - 38.4 mg/dL
(Method: Urease)

S.Creatinine 1.0 mg/dL 0.5 - 1.0 mg/dL

(Method: Enzymatic)

Interpretation

*** END OF REPORT ***

Please correlate clinically

Test Performed By : cljyothi Consultant Biochemist

https://tdiagnostics.telangana.gov.in/ViewFiles.aspx?ReportId=ZObjwyMeyYW0qG55yn7Crg== 11/13/24, 3 58 PM
Page 9 of 13
:
 Patient Name: K ESWAR CHANDRA Ref. Doctor: Dr.K R .Nikhila
Patient Id: 0001729851 Lab Id: 12232743211
OP Id: HY-BHS-1223-00023 Sample Collection Date & Time: 09/10/2024 11:23 AM
Age/Gender: 19 Years/Male Reporting Date & time: 09/10/2024 06:00 PM

CLINICAL BIOCHEMISTRY
Investigation Result Biological Reference Interval

Specimen:Serum
S. Calcium 9.1 mg/dL 8.8 - 10.6 mg/dL
(Method: Arsenazo III)

Interpretation Used in diagnosis & monitoring of a wide range of disorders , including disorders of protein & vitamin D
& diseases of bone, kidney, parathyroid gland or GI tract. Total protein & albumin should always be
measured simultaneously for proper interpretation of serum calcium levels
*** END OF REPORT ***

Please correlate clinically

Test Performed By : cldakshyyani Consultant Biochemist

https://tdiagnostics.telangana.gov.in/ViewFiles.aspx?ReportId=ZObjwyMeyYW0qG55yn7Crg== 11/13/24, 3 58 PM
Page 10 of 13
:
 Patient Name: K ESWAR CHANDRA Ref. Doctor: Dr.K R .Nikhila
Patient Id: 0001729851 Lab Id: 12232743211
OP Id: HY-BHS-1223-00023 Sample Collection Date & Time: 09/10/2024 11:23 AM
Age/Gender: 19 Years/Male Reporting Date & time: 09/10/2024 05:59 PM

CLINICAL BIOCHEMISTRY
Investigation Result Biological Reference Interval

Specimen:Serum
S.Uric Acid 7.7 mg/dL 3.5 - 7.2 mg/dL
(Method: Uricase)
*** END OF REPORT ***

Please correlate clinically

Test Performed By : cldakshyyani Consultant Biochemist

https://tdiagnostics.telangana.gov.in/ViewFiles.aspx?ReportId=ZObjwyMeyYW0qG55yn7Crg== 11/13/24, 3 58 PM
Page 11 of 13
:
 Patient Name: K ESWAR CHANDRA Ref. Doctor: Dr.K R .Nikhila
Patient Id: 0001729851 Lab Id: 12232743211
OP Id: HY-BHS-1223-00023 Sample Collection Date & Time: 09/10/2024 11:24 AM
Age/Gender: 19 Years/Male Reporting Date & time: 10/10/2024 04:04 AM

CLINICAL BIOCHEMISTRY
Investigation Result Biological Reference Interval

Specimen:Serum
Vitamin - D3 16.60 ng/ml Deficient < 10
(Method: CLIA)
Insufficient 10 - 29
Sufficient 30 - 100
Potential Toxicity > 100
Interpretation 1. Vitamin D is a steroid hormone involved in the intestinal absorption of calcium and the regulation of
calcium homeostasis. Vitamin D is essential for the formation and maintenance of strong, healthy bones.
2. Vitamin D deficiency can result from inadequate exposure to the sun, inadequate alimentary intake,
decreased absorption, abnormal metabolism, or vitamin D resistance Recently, many chronic diseases
such as cancer, high blood pressure. osteoporosis, and several autoimmune diseases have been linked to
vitamin D deficiency.
*** END OF REPORT ***

Please correlate clinically

Test Performed By : cljyothi Consultant Biochemist

https://tdiagnostics.telangana.gov.in/ViewFiles.aspx?ReportId=ZObjwyMeyYW0qG55yn7Crg== 11/13/24, 3 58 PM
Page 12 of 13
:
 Patient Name: K ESWAR CHANDRA Ref. Doctor: Dr.K R .Nikhila
Patient Id: 0001729851 Lab Id: 12232743211
OP Id: HY-BHS-1223-00023 Sample Collection Date & Time: 09/10/2024 11:23 AM
Age/Gender: 19 Years/Male Reporting Date & time: 10/10/2024 05:22 AM

CLINICAL BIOCHEMISTRY
Investigation Result Biological Reference Interval

Specimen:Serum
S.Magnesium 2.0 mg/dl 1.6 - 2.6
(Method: Xylidyl blue)

Interpretation 1. Magnesium is primarily an intracellular ion associated with gastrointestinal (GI) absorption and renal
excretion. It is the fourth most abundant cation in the body and is second to potassium within cell. It is
stored in bones, skeletal muscles and other cells and only a part in extracellular fluid. Mg is a cofactor of
many enzyme system concerned with call respiration, glycolysis, transmembrane transport of other
cations such as calcium and sodium. The activity of Na-K-ATPase pump depends on magnesium.
2. Assessment of magnesium level is used for the diagnosis and monitoring of hypomagnesemia or
hypermagnesemia.
3. Magnesium deficiency leads to impairment of neuromuscular functions resulting in hyperritability,
tetany, convulsion or electrocardiographic changes. It is also associated with cardiovascular diseases such
as hypertension, myocardial infarction, cardiac dysrhythmias, coronary vasupaam & premature
atherosclerosis. Diabetic ketoacidosis, chronic alcoholism, malnutrition, lactation malabsorption are other
conditions linked with it.
4. Increased serum magnesium concentration has been observed in dehydration, Addison's disease,
rhabdomyolysis or acute or chronic renal failure.
*** END OF REPORT ***

Please correlate clinically

Test Performed By : cljyothi Consultant Biochemist

https://tdiagnostics.telangana.gov.in/ViewFiles.aspx?ReportId=ZObjwyMeyYW0qG55yn7Crg== 11/13/24, 3 58 PM
Page 13 of 13
: